Corrado Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Corrado Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 09, 2019	SELL	$8.38 - $13.44 $312,783 - $501,648	-37,325 Closed	0 $0
Q3 2018 Oct 11, 2018	BUY	$11.6 - $16.54 $5,278 - $7,525	455 Added 1.23%	37,325 $451,000
Q2 2018 Jul 09, 2018	BUY	$13.13 - $17.09 $59,268 - $77,144	4,514 Added 13.95%	36,870 $575,000
Q1 2018 Apr 06, 2018	SELL	$13.76 - $17.12 $28,208 - $35,096	-2,050 Reduced 5.96%	32,356 $487,000
Q3 2017 Oct 06, 2017	BUY	$11.74 - $15.78 $403,926 - $542,926	34,406	34,406 $519,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corrado Advisors, LLC with notifications on news.